About the Authors
- Elena Lara-Simon
-
Roles Data curation, Formal analysis, Investigation, Software, Writing – original draft
Affiliation Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain
- Juan Domingo Gispert
-
Roles Conceptualization, Supervision, Writing – review & editing
Affiliation Barcelona Beta Research Center, Barcelona, Spain
- Jordi Garcia-Ojalvo
-
Roles Conceptualization, Investigation, Supervision, Validation, Writing – review & editing
Affiliation Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain
- Pablo Villoslada
-
Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing – review & editing
* E-mail: pablo.villoslada@upf.edu
Affiliations Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain, Hospital del Mar Research Institute, Barcelona, Spain
- for the Alzheimer’s Disease Neuroimaging Initiative
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: PV has received consultancy fees and holds stocks in Bionure Investment, Accure Therapeutics, Attune Neurosciences, QMENTA, CLight, NeuroPrex, Spiral Therapeutics, and Adhera Health, none related to this study. PV holds patent rights and has received royalties and consultancy fees from Oculis Holding AG for using OCS-05 (aka BN201) to treat optic neuritis (NCT04762017). JDG is currently an employee at Astra-Zeneca, but his contribution were done before joining the company. All the other authors have declared that no competing interests exist.